Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
AVTRthis companyAvantor, Inc.	$15.59	-14.69×	1.4×	1.19×	81.84×	23.5%	32.7%	-3.8%	-8.1%	-9.5%	-2.4%	6.4%	0.71×	25.82×	-1.45×	1.78×	0.0%	7	2.17	3	B+
AZTAAzenta, Inc.	$39.97	-23.54×	0.76×	2.21×	21.18×	-69.9%	45.5%	-1.9%	-9.4%	-3.2%	2.1%	2.9%	0.06×	-3.12×	0×	2.98×	0.0%	4	3.8	2	C+
BIOBio-Rad Laboratories, Inc.	$386.07	10.87×	1.11×	3.2×	7.65×	-146.4%	52.0%	10.5%	29.4%	10.2%	2.0%	4.5%	0.21×	0.83×	5.52×	5.62×	0.0%	7	3.65	3	B
CRLCharles River Laboratories International, Inc.	$350.93	-69.99×	3.19×	2.51×	31.51×	-76.6%	30.5%	12.6%	-3.6%	-4.6%	8.4%	5.1%	0.97×	6.94×	4.74×	1.29×	0.0%	5	2.99	1	C-
DHRDanaher Corporation	$230.96	45.15×	3.08×	6.59×	25.3×	-14.1%	60.9%	20.9%	14.7%	6.9%	5.7%	3.2%	0.35×	1.99×	19.38×	1.87×	0.5%	7	3.74	3	B
RGENRepligen Corporation	$176.40	188.34×	4.38×	12.48×	51.17×	-83.4%	47.1%	8.1%	6.6%	2.3%	1.6%	1.0%	0.33×	0.68×	2.57×	8.37×	0.0%	4	9.05	1	C-
Peer median	—	10.87×	3.08×	3.2×	25.3×	-76.6%	47.1%	10.5%	6.6%	2.3%	2.1%	3.2%	0.33×	0.83×	4.74×	2.98×	0.0%	5	3.74	2	—